Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma

Journal of the American Academy of Dermatology

Volumn 72, Issue 1, 2015, Pages 78-84

  Famenini, Shannon ^a   Martires, Kathryn J ^b   Zhou, Hui ^c   Xavier, Marin F ^d   Wu, Jashin J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c Department of Research and Evaluation Kaiser Permanente Southern California ^*  (United States)

^d SCRIPPS CLINIC   (United States)

Author keywords

chronic lymphocytic leukemia; immunodeficiency; melanoma; non Hodgkin lymphoma

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CAUCASIAN; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; MITOSIS RATE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; RETROSPECTIVE STUDY; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, NON-HODGKIN; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84916918507     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.09.030     Document Type: Article

References (38)

1. A.M. Tsimberidou, S. Wen, P. McLaughlin, S. O'Brien, W.G. Wierda, and S. Lerner Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma J Clin Oncol 27 2009 904 910
2. Leukemia and Lymphoma Society. Facts 2013. Available from: URL: http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/generalcancer/pdf/facts.pdf. Accessed September 8, 2013.
3. A.D. Hamblin, and T.J. Hamblin The immunodeficiency of chronic lymphocytic leukemia Br Med Bull 87 2008 49 62
4. J.A. Royle, P.D. Baade, D. Joske, J. Girschik, and L. Fritsch Second cancer incidence and cancer mortality among chronic lymphocytic leukemia patients: a population-based study Br J Cancer 105 2011 1076 1081
5. D.B. McKenna, V.R. Doherty, K.M. McLaren, and J.A. Hunter Malignant melanoma and lymphoproliferative malignancy: is there a shared etiology? Br J Dermatol 143 2000 171 173
6. J. Adami, M. Frisch, J. Yuen, B. Glimelius, and M. Melbye Evidence of an association between non-Hodgkin's lymphoma and skin cancer BMJ 310 1995 1491 1495
7. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumors of hematopoietic and lymphoid tissues. WHO Publications Center. International Agency for Research on Cancer. 4th ed. 2008.
8. J. Pei, V. Robu, M. Feder, M. Cheung, E. Neumann-Dommer, and J. Talarcheck Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma Cancer Genet 207 2014 98 102
9. D.R. Friedman, J.E. Lucas, and J.B. Weinberg Clinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia PLoS One 8 2013 e57356
10. L.M. Morton, R.E. Curtis, M.S. Linet, E.C. Bluhm, M.A. Tucker, and N. Caporaso Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype J Clin Oncol 28 2010 4935 4944
11. J.D. Brewer, T.D. Shanafelt, C.C. Otley, R.K. Roenigk, J.R. Cerhan, and N.E. Kay Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study J Clin Oncol 30 2012 843 849
12. P. Brennan, G. Scelo, K. Hemminki, L. Mellemkjaer, E. Tracey, and A. Andersen Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma Br J Cancer 93 2005 159 166
13. S. Sacchi, L. Marcheselli, A. Bari, R. Marcheselli, S. Pozzi, and S. Luminari Secondary malignancies after treatment for non-Hodgkin's lymphoma: a 16-year follow-up study Haematologica 93 2008 398 404
14. B. Mukherji Immunology of melanoma Clin Dermatol 31 2013 156 165
15. A. Shai, I. Avinoach, and A. Sagi Metastatic malignant melanoma with spontaneous and complete regression of the primary lesion: case report and review of the literature J Dermatol Surg Oncol 20 1994 342 345
16. T. Boon, P.G. Coulie, and B.J. Van den Eynde Human T cell responses against melanoma Annu Rev Immunol 24 2006 175 208
17. B. Mukherji, A. Guha, N.G. Chakraborty, M. Sivanandham, A.L. Nashed, and J.R. Sporn Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma J Exp Med 169 1989 1961 1976
18. + T cells in cancer immunotherapy Curr Opin Immunol 91 1994 741 745
19. L.L. Mire, K. Hollywood, D. Gray, C. Bordea, and F. Wojnarowska Melanomas in renal transplant recipients Br J Dermatol 154 2006 472 477
20. A.G. Sheil Cancer after transplantation World J Surg 10 1986 389 396
21. J.J. Grob, S. Bastuji-Garin, L. Vaillant, J.C. Roujeau, P. Bernard, and B. Sassolas Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant recipients Invest Dermatol 107 1996 694 697
22. T.J. Kipps Chronic lymphocytic leukemia Curr Opin Hematol 7 2000 223 234
23. M. Cantwell, T. Hua, J. Pappas, and T.J. Kipps Acquired CD40-ligand deficiency in chronic lymphocytic leukemia Nat Med 3 1997 984 989
24. C. Lacombe, J. Gombert, B. Dreyfus, A. Brizard, and J.L. Preud'Homme Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia Clin Immunol 90 1999 128 132
25. C.C. Otley Non-Hodgkin lymphoma and skin cancer: a dangerous combination Australas J Dermatol 47 2006 231 236
26. P. McLaughlin, N. Fowler, N. Liu, and L.J. Medeiros Chapter 7: The indolent lymphomas H.M. Kantarjian, R.A. Wolff, C.A. Koller, The MD Anderson manual of medical oncology 2nd ed. 2011 McGraw-Hill New York
27. E. Irie, Y. Shirota, C. Suzuki, Y. Tajima, K. Ishizawa, and J. Kameoka Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis Int J Hematol 91 2010 501 508
28. K. Rashid, R. Ng, A. Mastan, D. Sager, and R. Hirschman Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia Leuk Lymphoma 46 2005 1051 1055
29. Y. Davidovitz, A. Ballin, and D. Meytes Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia Acta Haematol 98 1997 44 46
30. A. Foss Abrahamsen, A. Andersen, O. Nome, A.B. Jacobsen, H. Holte, and J. Foss Abrahamsen Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time Ann Oncol 13 2002 1786 1791
31. J.J. Van den Oord, N. Vandeghinste, M. De Ley, and C. De Wolf-Peeters Bcl-2 expression in human melanocytes and melanocytic tumors Am J Pathol 145 1994 294 300
32. M.C. Saenz-Santamaria, J.A. Reed, N.S. McNutt, and C.R. Shea Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi J Cutan Pathol 21 1994 393 397
33. + cells of patients with B-cell chronic lymphocytic leukemia Blood 89 1997 4275 4281
34. P. Boffetta, O. van der Hel, and A. Kricker Exposure to ultraviolet radiation and risk of malignant lymphoma and multiple myeloma-a multicenter European case-control study Int J Epidemiol 37 2008 1080 1094
35. B.K. Armstrong, and A. Kricker Sun exposure and non-Hodgkin lymphoma Cancer Epidemiol Biomarkers Prev 16 2007 396 400
36. Centers for Disease Control and Prevention. US cancer statistics. Available from: URL: http://apps.nccd.cdc.gov/uscs/toptencancers.aspx. Accessed June 18, 2013.
37. H.I. Hall, D.R. Miller, J.D. Rogers, and B. Bewerse Update on the incidence and mortality from melanoma in the United States J Am Acad Dermatol 40 1999 35 42
38. G.M. Dores, W.F. Anderson, R.E. Curtis, O. Landgren, E. Ostroumova, and E.C. Bluhm Chronic lymphocytic leukemia and small lymphocytic lymphoma: overview of the descriptive epidemiology Br J Haematol 139 2007 809 819